Pith. sign in

REVIEW 4 major objections 6 minor 132 references

Artificial Intelligence for Central Dogma-Centric Multi-Omics: Challenges and Breakthroughs

T0 review · 4 major / 6 minor · reviewed 2026-08-11 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗ Review JSON

Pith's one-line read This review argues that AI-driven multi-omics models—integrating DNA, RNA, and protein data along the central dogma—have improved disease prediction, helped identify disease-associated loci, and are advancing precision medicine.

desk verdict A useful but currently unreliable survey: the central-dogma framing and task-based tables are good, yet citation mismatches and an undefined equation undermine its value as a reference until fixed. read the letter →

arxiv 2412.12668 v1 pith:XKQCBXCA submitted 2024-12-17 q-bio.GN

Lei Xin , Caiyun Huang , Hao Li , Shihong Huang , Yuling Feng , Zhenglun Kong , Zicheng Liu , Siyuan Li
show 3 more authors
Chang Yu Fei Shen Hao Tang
This is my paper · ORCID
classification q-bio.GN
keywords multi-omicscentraldogmaartificialintelligencemachinelearningdeepfoundationmodeldiseasepredictionprecisionmedicine
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper is a wide survey, drawing on more than 130 studies, of how artificial intelligence is used to analyze multi-omics data. Its central argument is that single-omics approaches—genomics, transcriptomics, proteomics, metabolomics taken alone—are too noisy and high-dimensional to reliably distinguish disease subtypes, whereas AI models that integrate multiple omics layers along the central dogma (DNA → RNA → protein) improve disease prediction and reveal disease-associated genetic loci. The review organizes the field into three fusion strategies, four deep-learning task families, and a new wave of foundation models pretrained on large-scale biological sequences. The practical payoff, if the surveyed results are accurate, is a pathway toward precision medicine in which disease subtypes and drug responses are predicted from integrated molecular profiles.

What carries the argument

The conceptual axis is the central dogma of molecular biology ($\mathrm{DNA} \to \mathrm{RNA} \to \mathrm{protein}$), which supplies the biological rationale for combining omics layers. The technical machinery is a short list of multimodal alignment mechanisms: the linear projector $Y = WX + B$, the multilayer perceptron with nonlinear activations $Y = f(W_2 f(W_1 X + B_1) + B_2)$, cross-attention $\mathrm{Attention}(K,Q,V) = \mathrm{softmax}(QK^{\mathsf{T}} / \sqrt{d_k})V$, and the Q-Former, a lightweight Transformer that converts variable-length inputs into fixed-length learned queries. The same section also defines the two-stage pretraining paradigm for foundation models—first on single-molecule sequences, then on multiple molecules with learned weights—as the mechanism for teaching models the cross-molecular interactions of the central dogma.

What would settle it

Re-run the headline benchmark comparisons on their stated public datasets and check whether the reported numbers reproduce; for example, test whether the 99.8% pan-cancer accuracy, the 99.16% five-dataset average, and the 94.68% graph-attention accuracy hold, and verify whether the references for CELLama and SCimilarity in Section 5.5 are the papers actually cited there. Any large shortfall or citation mismatch would undercut the review's map of the field.

Watch

Extended reading notes

Core claim

The paper claims that deep learning has become the most effective tool for integrating the molecular layers described by the central dogma, and that this integration measurably improves disease modeling. It assembles a series of reported results: a self-normalizing network classifies 33 cancer types with 99.8% accuracy; a supervised multi-head attention transformer reaches an average 99.16% accuracy across five TCGA cancer datasets; a graph attention model improves cancer classification by about 4.69% over graph convolutional networks; an autoencoder improves liver-cancer survival prediction (C-index 0.68 versus 0.62 for PCA); regression models predict gene expression and drug response from DNA methylation, RNA, and protein features; and generative models produce synthetic single-cell and EHR data. For foundation models, the review points to large pretrained systems—cited examples include scGPT, Evo, CD-GPT, and LucaOne—that transfer to cell annotation, batch integration, perturbation response prediction, and gene-network inference. The organizing contribution of the review is a taxonomy: post-fusion strategies (linear projector, MLP, cross-attention, Q-Former) and four task families (classification, regression, generation, clustering), with central-dogma-aware two-stage pretraining as the emerging frontier.

Load-bearing premise

The review is a secondhand report, so its conclusions stand or fall on whether the performance numbers and reference attributions it transcribes from the cited studies are accurate; in Section 5.5 the markers [47] and [48] are attached to CELLama and SCimilarity even though those references are DRPBind and SPHINKS, and Equation (4) contains undefined symbols.

Editorial extensions

If this is right

  • If the central claim holds, multi-omics deep-learning classifiers are already accurate enough (above 99% in some reported cases) that remaining progress in disease subtyping will come from data coverage and model interpretability rather than from any single omics layer.
  • Generative models become a practical solution for data sparsity and privacy: synthetic multi-omics and single-cell samples can be produced when real samples are scarce or too sensitive to share.
  • Foundation models pretrained on large molecular-sequence corpora will keep absorbing central-dogma structure, making transfer across cell types, tissues, and species more reliable.
  • Cross-attention and Q-Former-style fusion should spread from vision-language and RNA-generation tasks to general multi-omics integration, since they explicitly model interactions between DNA, RNA, and protein rather than concatenating features.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The review's retrospective evidence does not itself prove that AI-driven multi-omics models improve disease prediction; the decisive test would be prospective: use such a model to nominate new disease loci or drug targets and validate them experimentally.
  • The taxonomy implies a controlled experiment the paper does not run: fix the downstream task and vary only the fusion strategy (linear projector versus MLP versus cross-attention) to separate the effect of fusion choice from model scale and data volume.
  • If the central dogma is a genuine biological prior, then cross-species transfer of foundation models should improve with model size; this is testable on the evaluation benchmarks the paper cites, extending the single-cell cell-atlas results to proteomic and metabolomic layers.
Share X Bluesky LinkedIn Reddit HN

Signed reviews

No signed human review yet.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 6 minor

Summary. This manuscript is a survey of artificial intelligence and deep learning methods for central-dogma-centric multi-omics data. It organizes more than 130 references into four task categories—classification, regression, generation, and clustering—and discusses foundation models, long-sequence modeling, evaluation benchmarks, and emerging frontiers. The paper's central claim, stated in the abstract, is that AI-driven multi-omics models have improved disease-prediction accuracy and advanced precision medicine. As a review, the paper contributes no new quantitative results; its value depends entirely on the accuracy of its synthesis, its mathematical descriptions, and its citation attributions.

Significance. If the reference attributions and mathematical descriptions were accurate, this survey would be a useful entry point for computational biologists: it covers a timely topic, organizes a large literature, and makes a plausible case that AI-based integration of genomic, transcriptomic, and proteomic data can improve disease modeling. The organization by task type and the emphasis on foundation models are strengths. However, the paper currently contains several concrete citation mismatches and one undefined equation, and because these occur in the tables and sections that carry the survey's evidence, the central claim cannot be fully verified as written. The appropriate standard for a survey is the reliability of its synthesis; that standard is not yet met.

major comments (4)
  1. [Section 2, Eq. (4)] The Q-Former paragraph introduces a formula with symbols G_r and sigma_r that are never defined, and the displayed expression does not correspond to the described 'learnable query embeddings interact with input features via multi-head attention and cross-attention' mechanism. Since the abstract promises mathematical definitions, an undefined equation is a substantive gap; either define all symbols and connect the formula to the Q-Former architecture, or delete it.
  2. [Section 5.5, references [47] and [48]] The text states that CELLama [47] transforms cell data into 'sentences' and that SCimilarity [48] uses metric learning. In the reference list, [47] is DRPBind (Sharma et al., bioRxiv 2023) and [48] is SPHINKS (Migliozzi et al., Nature Cancer 2023); neither is the cited method. The actual CELLama and SCimilarity papers appear to be missing from the reference list, so this passage cannot be checked.
  3. [Table 4 and Section 3.4] Table 4 assigns CLCluster to reference [85], but [85] is NetICS (Dimitrakopoulos et al., Bioinformatics 2018); the body text in Section 3.4 correctly cites CLCluster as [101]. The same table assigns GRMEC-SC to [101], but [101] is CLCluster and the GRMEC-SC paper is [100]; the scMDC row is listed as [100] although [100] is GRMEC-SC and scMDC is reference [103]. These mismatches, in the very table that carries the clustering evidence, make it impossible to verify which reported result belongs to which method.
  4. [Abstract and Section 2] The abstract says the paper 'reviews the mathematical definitions of multi-omics,' but Section 2 only provides generic formulas for linear projection, an MLP, attention, and an undefined Q-Former expression; it never defines a multi-omics dataset or the integration problem mathematically. This discrepancy should be fixed either by adding a formal problem statement or by softening the abstract's claim.
minor comments (6)
  1. [Section 3.1] The opening sentence claims SVM was 'widely used in early multi-omics classification tasks' and cites [47,48]; however, [47] is a single-sequence binding-residue prediction method rather than a multi-omics integration study, and [48] is a single multi-omics subtype-classification paper. A broader and more apt set of citations is needed to support the 'widely used' claim.
  2. [References [15] and [27]] References [15] and [27] are the same article (Nemeth et al., Nature Reviews Genetics 2023) but are cited as separate entries; these should be unified into a single reference.
  3. [Table 2, row for Seal et al.] Table 2 lists the venue for Seal et al. as 'Genomics 2022', but reference [59] is dated 2020 (Genomics 112(4), 2833-2841); the year should be aligned with the reference list.
  4. [Section 5.5, reference [127]] The text says 'Rosen et al. [127] developed a universal cell embedding,' but reference [127] is by Heimberg et al., not Rosen et al.; the author attribution is incorrect.
  5. [Figure 1] Figure 1's timeline cites [35]-[40] as milestones for SVM, random forest, RNN, VAE, Transformer, and LLM, but these references are bioinformatics applications rather than the original sources of those methods; the figure should clarify that the timeline marks their emergence in multi-omics, not their invention.
  6. [Reference list] The reference list has several formatting inconsistencies: many entries use 'al.' instead of 'et al.' and some author fields are malformed (e.g., [31] reads 'Huo, L., Jiao, J. Li, Chen, L.'); a full proofread of the reference list is needed.

Circularity Check

0 steps flagged · score 0.0 of 10

No significant circularity: this survey makes no independent predictions and fits no parameters; its claims rest on external citations, and the citation errors it contains are accuracy problems, not circular reasoning.

full rationale

This paper is a literature survey, not a derivation-based study. Its central claim—that numerous AI studies have developed multi-omics models that improve disease prediction and advance precision medicine—is a restatement of more than 130 externally cited works; the paper itself computes no new result, fits no parameter, and reports no benchmark of its own. There is therefore no input–output chain that could reduce to itself. I found no self-citations: scanning the reference list, none of the present authors (Xin, Huang, Li, Huang, Feng, Kong, Liu, Li, Yu, Shen, Tang) appear as authors of any cited work, so no load-bearing premise rests on the authors' own prior results or on any imported 'uniqueness theorem.' The Q-Former description in Eq. (4) is garbled (undefined Gr and sigma_r, with an unexplained image-oriented formula), and several reference mappings are wrong—Section 5.5 attributes CELLama and SCimilarity to [47] and [48], which the reference list assigns to DRPBind and SPHINKS, and Table 4 lists CLCluster as [85] and GRMEC-SC as [101] while those numbers instead correspond to NetICS and CLCluster respectively. However, these are attribution-fidelity errors that make the survey's evidence base difficult to verify as written; they are not instances of a prediction being equivalent to its own inputs, of a fitted parameter being renamed a prediction, or of a self-citation chain forcing a conclusion. Per the analysis rules, inaccuracies in external citation belong under correctness risk, not circularity. Accordingly the circularity score is 0.

Assumptions & free parameters 0 free parameters · 2 assumptions · 0 invented entities

Since the paper is a review, it introduces no free parameters or invented entities. Its epistemic burden is the faithful summarization of prior literature.

assumptions (2)
  • domain assumption The central dogma (DNA to RNA to protein) is assumed as the organizing biological framework for multi-omics integration.
    Used throughout Sections 1 and 2 to define which omics layers matter and how they should be aligned.
  • domain assumption Performance figures and conclusions from the 130+ cited papers are assumed to be correctly summarized and comparable.
    The review's utility depends on faithful reporting of prior results; citation mismatches in Section 5.5 and the garbled Eq. (4) weaken this assumption.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Artificial Intelligence for Central Dogma-Centric Multi-Omics: Challenges and Breakthroughs." pith.science (2026). https://pith.science/paper/XKQCBXCA

@misc{pith2026241212668,
  author       = {Pith},
  title        = {Pith review of: Artificial Intelligence for Central Dogma-Centric Multi-Omics: Challenges and Breakthroughs},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/XKQCBXCA}},
  note         = {Machine review of arXiv:2412.12668}
}
read the original abstract

With the rapid development of high-throughput sequencing platforms, an increasing number of omics technologies, such as genomics, metabolomics, and transcriptomics, are being applied to disease genetics research. However, biological data often exhibit high dimensionality and significant noise, making it challenging to effectively distinguish disease subtypes using a single-omics approach. To address these challenges and better capture the interactions among DNA, RNA, and proteins described by the central dogma, numerous studies have leveraged artificial intelligence to develop multi-omics models for disease research. These AI-driven models have improved the accuracy of disease prediction and facilitated the identification of genetic loci associated with diseases, thus advancing precision medicine. This paper reviews the mathematical definitions of multi-omics, strategies for integrating multi-omics data, applications of artificial intelligence and deep learning in multi-omics, the establishment of foundational models, and breakthroughs in multi-omics technologies, drawing insights from over 130 related articles. It aims to provide practical guidance for computational biologists to better understand and effectively utilize AI-based multi-omics machine learning algorithms in the context of central dogma.

Discussion (0). Continue with ORCID to comment.

Reference graph

Works this paper leans on

132 extracted references · 65 canonical work pages

  1. [47]

    bioRxiv, 2023–0320533427 (2023)

    Sharma, R., Tsunoda, T., Sharma, A.: Drpbind: prediction of dna, rna and protein binding residues in intrinsically disordered protein sequences. bioRxiv, 2023–0320533427 (2023)

    2023

  2. [48]

    Nature Cancer 4(2), 181–202 (2023)

    Migliozzi, S., Oh, Y.T., Hasanain, M., al.: Integrative multi-omics networks identify pkcδ and dna-pk as master kinases of glioblastoma subtypes and guide targeted cancer therapy. Nature Cancer 4(2), 181–202 (2023)

    2023

  3. [85]

    Bioinformatics 34(14), 2441–2448 (2018)

    Dimitrakopoulos, C., Hindupur, S.K., H¨ afliger, L., al.: Network-based integra- tion of multi-omics data for prioritizing cancer genes. Bioinformatics 34(14), 2441–2448 (2018)

    work page 2018

  4. [101]

    bioRxiv, 2024–0307584010 (2024)

    Wang, H., Zhang, Y., Li, W., al.: Clcluster: a redundancy-reduction contrastive learning-based clustering method of cancer subtype based on multi-omics data. bioRxiv, 2024–0307584010 (2024)

    work page 2024

  5. [100]

    Bioinformatics 40(4), 169 (2024)

    Chen, F., Zou, G., Wu, Y., al.: Clustering single-cell multi-omics data via graph regularized multi-view ensemble learning. Bioinformatics 40(4), 169 (2024)

    work page 2024

  6. [103]

    Nature Communications 13(1), 7705 (2022)

    Lin, X., Tian, T., Wei, Z., al.: Clustering of single-cell multi-omics data with a multimodal deep learning method. Nature Communications 13(1), 7705 (2022)

    work page 2022

  7. [1]

    Nucleic Acids Research 51(D1), 977–985 (2023)

    Sollis, E., Mosaku, A., Abid, A., al.: The nhgri-ebi gwas catalog: knowledgebase and deposition resource. Nucleic Acids Research 51(D1), 977–985 (2023)

    2023

  8. [2]

    Nature577, 179–189 (2020) 17

    Claussnitzer, M.: A brief history of human disease genetics. Nature577, 179–189 (2020) 17

    2020

Show all 132 references
  1. [3]

    The American Journal of Human Genetics 101(1), 5–22 (2017)

    Visscher, P.M., Wray, N.R., Zhang, Q., al.: 10 years of gwas discovery: biology, function, and translation. The American Journal of Human Genetics 101(1), 5–22 (2017)

    2017

  2. [4]

    Analytical Chemistry 91, 2155–2162 (2019)

    Blaˇ zenovi´ c, I.: Structure annotation of all mass spectra in untargeted metabolomics. Analytical Chemistry 91, 2155–2162 (2019)

    2019

  3. [5]

    Metabolites 10, 160 (2020)

    Hassanpour, N., al.: Biological filtering and substrate promiscuity prediction for annotating untargeted metabolomics. Metabolites 10, 160 (2020)

    2020

  4. [6]

    Nature Communications 12, 3832 (2021)

    Schmid, R., al.: Ion identity molecular networking for mass spectrometry- based metabolomics in the gnps environment. Nature Communications 12, 3832 (2021)

    2021

  5. [7]

    Nature 626(7998), 419–426 (2024)

    Gentry, E.C., Collins, S.L., Panitchpakdi, M., al.: Reverse metabolomics for the discovery of chemical structures from humans. Nature 626(7998), 419–426 (2024)

    2024

  6. [8]

    Nature Reviews Molecular Cell Biology 24, 695–713 (2023)

    Baysoy, A., Bai, Z., Satija, R., Fan, R.: The technological landscape and appli- cations of single-cell multi-omics. Nature Reviews Molecular Cell Biology 24, 695–713 (2023)

    2023

  7. [9]

    Nature 576(7787), 487–491 (2019)

    Argelaguet, R., Clark, S.J., Mohammed, H., al.: Multi-omics profiling of mouse gastrulation at single-cell resolution. Nature 576(7787), 487–491 (2019)

    2019

  8. [10]

    Nature 513(7518), 382–387 (2014)

    Zhang, B., Wang, J., Wang, X., al.: Proteogenomic characterization of human colon and rectal cancer. Nature 513(7518), 382–387 (2014)

    2014

  9. [11]

    Proceedings of the National Academy of Sciences 101(48), 16855–16860 (2004)

    Zhang, L., Kasif, S., Cantor, C.R., al.: Gc/at-content spikes as genomic punc- tuation marks. Proceedings of the National Academy of Sciences 101(48), 16855–16860 (2004)

    2004

  10. [12]

    Biochemical and Biophysical Research Communications 452, 294–301 (2014)

    Takahashi, H., Carninci, P.: Widespread genome transcription: new possibilities for rna therapies. Biochemical and Biophysical Research Communications 452, 294–301 (2014)

    2014

  11. [13]

    Nucleic Acids Research 47(15), 8111–8125 (2019)

    Lu, S., Zhang, J., Lian, X., al.: A hidden human proteome encoded by ‘non- coding’ genes. Nucleic Acids Research 47(15), 8111–8125 (2019)

    2019

  12. [14]

    Cell Research, 1–21 (2024)

    Poliseno, L., Lanza, M., Pandolfi, P.P.: Coding, or non-coding, that is the question. Cell Research, 1–21 (2024)

    2024

  13. [16]

    Nature Reviews Molecular Cell Biology 24(6), 430–447 (2023) 18

    Mattick, J.S., Amaral, P.P., Carninci, P., al.: Long non-coding rnas: defini- tions, functions, challenges and recommendations. Nature Reviews Molecular Cell Biology 24(6), 430–447 (2023) 18

    2023

  14. [17]

    Human Molecular Genetics 24(R1), 102–110 (2015)

    Zhang, F., Lupski, J.R.: Non-coding genetic variants in human disease. Human Molecular Genetics 24(R1), 102–110 (2015)

    2015

  15. [18]

    Nature Reviews Molecular Cell Biology 22(2), 96–118 (2021)

    Statello, L., Guo, C.J., Chen, L.L., al.: Gene regulation by long non-coding rnas and its biological functions. Nature Reviews Molecular Cell Biology 22(2), 96–118 (2021)

    2021

  16. [19]

    Cell Signalling 101, 110504 (2023)

    Shirvani, H., Ghanavi, J., Aliabadi, A., Mousavinasab, F., Talebi, M., Majid- poor, J., al.: Mir-211 plays a dual role in cancer development: from tumor suppressor to tumor enhancer. Cell Signalling 101, 110504 (2023)

    2023

  17. [20]

    Cell Signalling 101, 110525 (2023)

    Khasraghi, L.B., Nouri, M., Vazirzadeh, M., Hashemipour, N., Talebi, M., Zarch, F.A., al.: Microrna-206 in human cancer: mechanistic and clinical perspectives. Cell Signalling 101, 110525 (2023)

    2023

  18. [21]

    Journal of Allergy and Clinical Immunol- ogy 141(4), 1202–1207 (2018)

    Lu, T.X., Rothenberg, M.E.: Microrna. Journal of Allergy and Clinical Immunol- ogy 141(4), 1202–1207 (2018)

    2018

  19. [22]

    Nature Reviews Molecular Cell Biology 20(1), 21–37 (2019)

    Gebert, L.F.R., MacRae, I.J.: Regulation of microrna function in animals. Nature Reviews Molecular Cell Biology 20(1), 21–37 (2019)

    2019

  20. [23]

    Science 386, 0799 (2024)

    Li, L., al.: Multi-omics landscape and molecular basis of radiation tolerance in a tardigrade. Science 386, 0799 (2024)

    2024

  21. [24]

    Trends in Genetics 29(1), 11–22 (2013)

    Y´ a˜ nez-Cuna, J.O., Kvon, E.Z., Stark, A.: Deciphering the transcriptional cis- regulatory code. Trends in Genetics 29(1), 11–22 (2013)

    2013

  22. [25]

    Nature Reviews Genetics 15(7), 453–468 (2014)

    Levo, M., Segal, E.: In pursuit of design principles of regulatory sequences. Nature Reviews Genetics 15(7), 453–468 (2014)

    2014

  23. [26]

    Trends in Biochemical Sciences 48(5), 450–462 (2023)

    Pobbati, A.V., Kumar, R., Rubin, B.P., al.: Therapeutic targeting of tead transcription factors in cancer. Trends in Biochemical Sciences 48(5), 450–462 (2023)

    2023

  24. [27]

    Nature Reviews Genetics 25(3), 211–232 (2024)

    Nemeth, K., Bayraktar, R., Ferracin, M., al.: Non-coding rnas in disease: from mechanisms to therapeutics. Nature Reviews Genetics 25(3), 211–232 (2024)

    2024

  25. [28]

    Annual Review of Pathology: Mechanisms of Disease 17(1), 295–321 (2022)

    Papanicolau-Sengos, A., Aldape, K.: Dna methylation profiling: an emerging paradigm for cancer diagnosis. Annual Review of Pathology: Mechanisms of Disease 17(1), 295–321 (2022)

    2022

  26. [29]

    Signal Transduction and Targeted Therapy 8(1), 310 (2023)

    Liu, R., Zhao, E., Yu, H., al.: Methylation across the central dogma in health and diseases: new therapeutic strategies. Signal Transduction and Targeted Therapy 8(1), 310 (2023)

    2023

  27. [30]

    BMC Gastroenterology 22(1), 308 (2022) 19

    Wang, M., Li, B., Chen, Y., al.: Teads serve as potential prognostic biomarkers and targets for human gastric cancer. BMC Gastroenterology 22(1), 308 (2022) 19

    2022

  28. [31]

    Li, Chen, L., al.: Single-cell multi-omics sequencing: application trends, covid-19, data analysis issues and prospects

    Huo, L., Jiao, J. Li, Chen, L., al.: Single-cell multi-omics sequencing: application trends, covid-19, data analysis issues and prospects. Briefings in Bioinformatics 22(6), 229 (2021)

    2021

  29. [32]

    Knowledge-Based Systems, 110937 (2023)

    Guo, K., Wu, M., Soo, Z., al.: Artificial intelligence-driven biomedical genomics. Knowledge-Based Systems, 110937 (2023)

    2023

  30. [33]

    Proceedings of the National Academy of Sciences 115(13), 2980–2987 (2018)

    Disselhorst, J.A., Krueger, M.A., Ud-Dean, S.M.M., al.: Linking imaging to omics utilizing image-guided tissue extraction. Proceedings of the National Academy of Sciences 115(13), 2980–2987 (2018)

    2018

  31. [34]

    Science 366, 447–453 (2019)

    Obermeyer, Z., Powers, B., Vogeli, C., Mullainathan, S.: Dissecting racial bias in an algorithm used to manage the health of populations. Science 366, 447–453 (2019)

    2019

  32. [35]

    Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1648(1-2), 127–133 (2003)

    Cai, Y., Lin, S.L.: Support vector machines for predicting rrna-, rna-, and dna-binding proteins from amino acid sequence. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1648(1-2), 127–133 (2003)

    2003

  33. [36]

    Bioinformatics 26(13), 1616– 1622 (2010)

    Liu, Z.P., Wu, L.Y., Wang, Y., al.: Prediction of protein–rna binding sites by a random forest method with combined features. Bioinformatics 26(13), 1616– 1622 (2010)

    2010

  34. [37]

    Nature Communications 7(1), 13090 (2016)

    Kim, M., Rai, N., Zorraquino, V., al.: Multi-omics integration accurately predicts cellular state in unexplored conditions for escherichia coli. Nature Communications 7(1), 13090 (2016)

    2016

  35. [38]

    In: 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), pp

    Zhang, X., Zhang, J., Sun, K., al.: Integrated multi-omics analysis using vari- ational autoencoders: application to pan-cancer classification. In: 2019 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), pp. 765–769 (2019)

    2019

  36. [39]

    bioRxiv, 2022–1114516459 (2022)

    Osseni, M.A., Tossou, P., Laviolette, F., al.: Mot: a multi-omics transformer for multiclass classification tumour types predictions. bioRxiv, 2022–1114516459 (2022)

    2022

  37. [40]

    arXiv preprint arXiv:2401.10034 (2024)

    Wu, X., Wu, S., Wu, J., al.: Evolutionary computation in the era of large language model: Survey and roadmap. arXiv preprint arXiv:2401.10034 (2024)

    2024 arXiv

  38. [41]

    Briefings in Bioinformatics 22(4), 287 (2021)

    Zuo, C., Chen, L.: Deep-joint-learning analysis model of single cell transcriptome and open chromatin accessibility data. Briefings in Bioinformatics 22(4), 287 (2021)

    2021

  39. [42]

    Molecular & Cellular Proteomics 22(6) (2023) 20

    Babu, M., Snyder, M.: Multi-omics profiling for health. Molecular & Cellular Proteomics 22(6) (2023) 20

    2023

  40. [43]

    Briefings in Bioinformatics 24(5), 304 (2023)

    Pang, J., Liang, B., Ding, R., al.: A denoised multi-omics integration frame- work for cancer subtype classification and survival prediction. Briefings in Bioinformatics 24(5), 304 (2023)

    2023

  41. [44]

    Nature Reviews Genetics 25, 597 (2024)

    Sakaue, S.: Scent defines non-coding disease mechanisms using single-cell multi- omics. Nature Reviews Genetics 25, 597 (2024)

    2024

  42. [45]

    In: Advances in Neural Information Processing Systems (2017)

    Vaswani, A.: Attention is all you need. In: Advances in Neural Information Processing Systems (2017)

    2017

  43. [46]

    In: Proceedings of the 40th International Conference on Machine Learning

    Li, J., Li, D., Savarese, S., al.: Blip-2: Bootstrapping language-image pre-training with frozen image encoders and large language models. In: Proceedings of the 40th International Conference on Machine Learning. Proceedings of Machine Learning Research, vol. 202, pp. 19730–19...

    2023

  44. [49]

    arXiv preprint arXiv:2001.01717 (2020)

    Ghaffar, F., Khan, S., Yu-jhen, C.: Macromolecule classification based on the amino-acid sequence. arXiv preprint arXiv:2001.01717 (2020)

    2020 arXiv

  45. [50]

    PLOS ONE 18(4), 0284563 (2023)

    Zhuang, Y., Xing, F., Ghosh, D., al.: Deep learning on graphs for multi-omics classification of copd. PLOS ONE 18(4), 0284563 (2023)

    2023

  46. [51]

    Academia Biology 2(3) (2024)

    Alharbi, F., Vakanski, A., Elbashir, M.K., al.: Lasso–mogat: a multi-omics graph attention framework for cancer classification. Academia Biology 2(3) (2024)

    2024

  47. [52]

    arXiv preprint arXiv:2408.02845 (2024)

    Tabakhi, S., Vandermeulen, C., Sudbery, I., al.: Heterogeneous graph attention network improves cancer multiomics integration. arXiv preprint arXiv:2408.02845 (2024)

    2024 arXiv

  48. [53]

    bioRxiv, 2023–1130569500 (2023)

    Mao, J., Wang, J., Zeb, A., al.: Multimodal generation of astrocyte by integrat- ing single-cell multi-omics data via deep learning. bioRxiv, 2023–1130569500 (2023)

    2023

  49. [54]

    In: 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), pp

    Pan, L., Qin, P., Rong, P., al.: Pacs: Prediction and analysis of cancer sub- types from multi-omics data based on a multi-head attention mechanism model. In: 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), pp. 904–909 (2023)

    2023

  50. [55]

    arXiv preprint 21 arXiv:2405.08226 (2024)

    Waqas, A., Tripathi, A., Ahmed, S., al.: Senmo: A self-normalizing deep learn- ing model for enhanced multi-omics data analysis in oncology. arXiv preprint 21 arXiv:2405.08226 (2024)

    2024 arXiv

  51. [56]

    arXiv preprint arXiv:2408.16245 (2024)

    Chen, S.F., Steele, R.J., Lemeneh, B., al.: Large-scale multi-omic biosequence transformers for modeling peptide-nucleotide interactions. arXiv preprint arXiv:2408.16245 (2024)

    2024

  52. [57]

    : Deep learning and multi-omics approach to predict drug responses in cancer

    Wang, C., et al. : Deep learning and multi-omics approach to predict drug responses in cancer. BMC Bioinformatics 22(Suppl 10), 632 (2021)

    2021

  53. [58]

    International Journal of Advanced Computer Science and Applications 14(5) (2023)

    Almutiri, T., Alomar, K., Alganmi, N.: Predicting drug response on multi-omics data using a hybrid of bayesian ridge regression with deep forest. International Journal of Advanced Computer Science and Applications 14(5) (2023)

    2023

  54. [59]

    : Estimating gene expression from dna methylation and copy number variation: a deep learning regression model for multi-omics integration

    Seal, D.B., et al. : Estimating gene expression from dna methylation and copy number variation: a deep learning regression model for multi-omics integration. Genomics 112(4), 2833–2841 (2020)

    2020

  55. [60]

    : The performance of deep generative models for learn- ing joint embeddings of single-cell multi-omics data

    Brombacher, E., et al. : The performance of deep generative models for learn- ing joint embeddings of single-cell multi-omics data. Frontiers in Molecular Biosciences 9, 962644 (2022)

    2022

  56. [61]

    arXiv preprint arXiv:2407.06405 (2024)

    Wu, Y., Xie, L.: Ai-driven multi-omics integration for multi-scale predic- tive modeling of causal genotype-environment-phenotype relationships. arXiv preprint arXiv:2407.06405 (2024)

    2024

  57. [62]

    In: Advances in Neural Information Processing Systems, vol

    Goodfellow, I., Pouget-Abadie, J., Mirza, M., al.: Generative adversarial nets. In: Advances in Neural Information Processing Systems, vol. 27 (2014)

    2014

  58. [63]

    arXiv preprint arXiv:1312.6114 (2013)

    Kingma, D.P.: Auto-encoding variational bayes. arXiv preprint arXiv:1312.6114 (2013)

    2013 arXiv

  59. [64]

    In: Advances in Neural Information Processing Systems, vol

    Ho, J., Jain, A., Abbeel, P.: Denoising diffusion probabilistic models. In: Advances in Neural Information Processing Systems, vol. 33, pp. 6840–6851 (2020)

    2020

  60. [65]

    bioRxiv, 2024– 0624600337 (2024)

    Zhu, X., Qin, C., Wang, F., al.: Cd-gpt: A biological foundation model bridging the gap between molecular sequences through central dogma. bioRxiv, 2024– 0624600337 (2024)

    2024

  61. [66]

    bioRxiv, 2024–0126577441 (2024)

    Mangnier, L., Bodein, A., Mariaz, M., al.: Decoding the microbiome- metabolome nexus: A systematic benchmark of integrative strategies. bioRxiv, 2024–0126577441 (2024)

    2024

  62. [67]

    Bioinformatics 37(16), 2231–2237 (2021)

    Yang, H., Chen, R., Li, D., al.: Subtype-gan: a deep learning approach for inte- grative cancer subtyping of multi-omics data. Bioinformatics 37(16), 2231–2237 (2021)

    2021

  63. [68]

    Genome Biology 22(1), 158 (2021)

    Yu, H., Welch, J.D.: Michigan: sampling from disentangled representations of 22 single-cell data using generative adversarial networks. Genome Biology 22(1), 158 (2021)

    2021

  64. [69]

    Briefings in Bioinformatics 22(4), 226 (2021)

    NuBberger, J., al.: Synthetic observations from deep generative models and binary omics data with limited sample size. Briefings in Bioinformatics 22(4), 226 (2021)

    2021

  65. [70]

    arXiv preprint arXiv:2405.09756 (2024)

    Al-Hurani, I., Alkhateeb, A., Ikki, S.: An autoencoder and generative adver- sarial networks approach for multi-omics data imbalanced class handling and classification. arXiv preprint arXiv:2405.09756 (2024)

    2024 arXiv

  66. [71]

    Bioinformatics 38(1), 179–186 (2022)

    Ahmed, K.T., Sun, J., Cheng, S., al.: Multi-omics data integration by generative adversarial network. Bioinformatics 38(1), 179–186 (2022)

    2022

  67. [72]

    PLOS ONE 18(2), 0281315 (2023)

    Khan, S.A., Lehmann, R., Martinez-de-Morentin, X., al.: scaegan: Unification of single-cell genomics data by adversarial learning of latent space correspondences. PLOS ONE 18(2), 0281315 (2023)

    2023

  68. [73]

    bioRxiv, 794289 (2019)

    Boyeau, P., Lopez, R., Regier, J., Gayoso, A., Jordan, M.I., Yosef, N.: Deep generative models for detecting differential expression in single cells. bioRxiv, 794289 (2019)

    2019

  69. [74]

    Bioinformatics 36(20), 5045–5053 (2020)

    Hess, M., Hackenberg, M., Binder, H.: Exploring generative deep learning for omics data using log-linear models. Bioinformatics 36(20), 5045–5053 (2020)

    2020

  70. [75]

    Scientific Reports 10(1), 9790 (2020)

    Bica, I., al.: Unsupervised generative and graph representation learning for modelling cell differentiation. Scientific Reports 10(1), 9790 (2020)

    2020

  71. [76]

    Genome Biology 24(1), 29 (2023)

    Choi, Y., Li, R., Quon, G.: sivae: interpretable deep generative models for single- cell transcriptomes. Genome Biology 24(1), 29 (2023)

    2023

  72. [77]

    AI 5(3), 1614–1632 (2024)

    Lee, H.S., Hong, S.H., Kim, G.H., al.: Generative models utilizing padding can efficiently integrate and generate multi-omics data. AI 5(3), 1614–1632 (2024)

    2024

  73. [78]

    Genome Biology 25(1), 198 (2024)

    Yang, X., Mann, K.K., Wu, H., al.: sccross: a deep generative model for unifying single-cell multi-omics with seamless integration, cross-modal generation, and in silico exploration. Genome Biology 25(1), 198 (2024)

    2024

  74. [79]

    Clinical Cancer Research 24(6), 1248–1259 (2018)

    Chaudhary, K., Poirion, O.B., Lu, L., al.: Deep learning–based multi-omics integration robustly predicts survival in liver cancer. Clinical Cancer Research 24(6), 1248–1259 (2018)

    2018

  75. [80]

    bioRxiv, 2024–0620599958 (2024)

    Zhang, X., Xiao, W., Cochran, B.H., al.: Deepsnap: human essential gene prediction by integrating multi-omics data. bioRxiv, 2024–0620599958 (2024)

    2024

  76. [81]

    arXiv preprint arXiv:2207.04878 (2022) 23

    Wu, X., Fang, Q.: Stacked autoencoder based multi-omics data integration for cancer survival prediction. arXiv preprint arXiv:2207.04878 (2022) 23

    2022 arXiv

  77. [82]

    npj Aging 10(1), 37 (2024)

    Sidorenko, D., Pushkov, S., Sakip, A., al.: Precious2gpt: the combination of multiomics pretrained transformer and conditional diffusion for artificial multi- omics multi-species multi-tissue sample generation. npj Aging 10(1), 37 (2024)

    2024

  78. [83]

    Scientific Reports 10(1), 8705 (2020)

    Sumathipala, M., Weiss, S.T.: Predicting mirna-based disease-disease rela- tionships through network diffusion on multi-omics biological data. Scientific Reports 10(1), 8705 (2020)

    2020

  79. [84]

    medRxiv, 2024–071124310294 (2024)

    Li, Z., Su, T., Zhang, B., al.: His-mmdmnetwork-based integration: Multi- domain and multi-omics translation of histopathology images with diffusion models. medRxiv, 2024–071124310294 (2024)

    2024

  80. [86]

    Frontiers in Genetics 11, 106 (2020)

    Di Nanni, N., Bersanelli, M., Milanesi, L., al.: Network diffusion promotes the integrative analysis of multiple omics. Frontiers in Genetics 11, 106 (2020)

    2020

  81. [87]

    Journal of Translational Medicine 22(1), 79 (2024)

    Duan, X., Ding, X., Zhao, Z.: Multi-omics integration with weighted affinity and self-diffusion applied for cancer subtypes identification. Journal of Translational Medicine 22(1), 79 (2024)

    2024

  82. [88]

    arXiv preprint arXiv:2408.08252 (2024)

    Li, X., Zhao, Y., Wang, C., al.: Derivative-free guidance in continuous and discrete diffusion models with soft value-based decoding. arXiv preprint arXiv:2408.08252 (2024)

    2024 arXiv

  83. [89]

    : Revolutionizing personalized medicine with generative ai: a systematic review

    Ghebrehiwet, I., et al. : Revolutionizing personalized medicine with generative ai: a systematic review. Artificial Intelligence Review 57(5), 1–41 (2024)

    2024

  84. [90]

    arXiv preprint arXiv:1701.07875 (2017)

    Arjovsky, M., Chintala, S., Bottou, L.: Wasserstein gan. arXiv preprint arXiv:1701.07875 (2017)

    2017 arXiv

  85. [91]

    Methods 226, 138–150 (2024)

    Afroz, S., Islam, N., Habib, M.A., al.: Multi-omics data integration and drug screening of aml cancer using generative adversarial network. Methods 226, 138–150 (2024)

    2024

  86. [92]

    Molecular Genetics and Genomics 298(4), 871–882 (2023)

    Shetty, K.S., Jose, A., Bani, M., al.: Network diffusion-based approach for survival prediction and identification of biomarkers using multi-omics data of papillary renal cell carcinoma. Molecular Genetics and Genomics 298(4), 871–882 (2023)

    2023

  87. [93]

    : Molecular design in drug discovery: a comprehensive review of deep generative models

    Cheng, Y., et al. : Molecular design in drug discovery: a comprehensive review of deep generative models. Briefings in Bioinformatics 22(6), 344 (2021)

    2021

  88. [94]

    : Tissue characterization at an enhanced resolution across spatial omics platforms with deep generative model

    Li, B., et al. : Tissue characterization at an enhanced resolution across spatial omics platforms with deep generative model. Nature Communications 15(1), 24 6541 (2024)

    2024

  89. [95]

    He, R.Y., et al.: Generative ai models in time varying biomedical data: a systematic review (2024)

    2024

  90. [96]

    Human Genetics141(9), 1481– 1498 (2022)

    Treppner, M., Binder, H., Hess, M.: Interpretable generative deep learning: an illustration with single cell gene expression data. Human Genetics141(9), 1481– 1498 (2022)

    2022

  91. [97]

    In: 2023 International Joint Conference on Neural Networks (IJCNN), pp

    Ali, S., Murad, T., Patterson, M.: Pcd2vec: A poisson correction distance based approach for viral host classification. In: 2023 International Joint Conference on Neural Networks (IJCNN), pp. 1–8 (2023)

    2023

  92. [98]

    bioRxiv (2024)

    Zhang, N., Casasent, T.D., Casasent, A.K., al.: Pca-plus: Enhanced princi- pal component analysis with illustrative applications to batch effects and their quantitation. bioRxiv (2024)

    2024

  93. [99]

    bioRxiv, 2024–0912612666 (2024)

    Tang, J., Chen, Z., Qian, K., al.: Interpretable high-resolution dimension reduc- tion of spatial transcriptomics data by spahdmap. bioRxiv, 2024–0912612666 (2024)

    2024

  94. [102]

    Medical Image Analysis 91, 103040 (2024)

    Xiao, X., Kong, Y., Li, R., al.: Transformer with convolution and graph-node co-embedding: an accurate and interpretable vision backbone for predicting gene expressions from local histopathological image. Medical Image Analysis 91, 103040 (2024)

    2024

  95. [104]

    arXiv preprint arXiv:1906.05474 (2019)

    Peng, Y., Yan, S., Lu, Z.: Transfer learning in biomedical natural language processing: an evaluation of bert and elmo on ten benchmarking datasets. arXiv preprint arXiv:1906.05474 (2019)

    2019 arXiv

  96. [105]

    In: Proceedings of NAACL-HLT, vol

    Kenton, J.D.M.W.C., Toutanova, L.K.: Bert: Pre-training of deep bidirectional transformers for language understanding. In: Proceedings of NAACL-HLT, vol. 1, p. 2 (2019)

    2019

  97. [106]

    arXiv preprint arXiv:1910.13461 (2019) 25

    Lewis, M.: Bart: Denoising sequence-to-sequence pre-training for natu- ral language generation, translation, and comprehension. arXiv preprint arXiv:1910.13461 (2019) 25

    2019 arXiv

  98. [107]

    bioRxiv, 2024–0227582234 (2024)

    Nguyen, E., Poli, M., Durrant, M.G., al.: Sequence modeling and design from molecular to genome scale with evo. bioRxiv, 2024–0227582234 (2024)

    2024

  99. [108]

    Nature Methods, 1–11 (2024)

    Cui, H., Wang, C., Maan, H., al.: scgpt: toward building a foundation model for single-cell multiomics using generative ai. Nature Methods, 1–11 (2024)

    2024

  100. [109]

    bioRxiv, 2024–0510592927 (2024)

    He, Y., Fang, P., Shan, Y., al.: Lucaone: Generalized biological foundation model with unified nucleic acid and protein language. bioRxiv, 2024–0510592927 (2024)

    2024

  101. [110]

    Nature Methods, 1–13 (2024)

    Hu, Y., Wan, S., Luo, Y., al.: Benchmarking algorithms for single-cell multi- omics prediction and integration. Nature Methods, 1–13 (2024)

    2024

  102. [111]

    arXiv preprint arXiv:2207.14639 (2022)

    Yang, H., Sheng, Y., Jiang, Y., al.: Subtype-former: a deep learning approach for cancer subtype discovery with multi-omics data. arXiv preprint arXiv:2207.14639 (2022)

    2022 arXiv

  103. [112]

    arXiv preprint arXiv:2409.02143 (2024)

    Yang, Z., Kotoge, R., Chen, Z., al.: Cmob: Large-scale cancer multi-omics bench- mark with open datasets, tasks, and baselines. arXiv preprint arXiv:2409.02143 (2024)

    2024 arXiv

  104. [113]

    Bioinformatics 40(Supplement 2), 198–207 (2024)

    Pfeifer, B., Sirocchi, C., Bloice, M.D., al.: Federated unsupervised random forest for privacy-preserving patient stratification. Bioinformatics 40(Supplement 2), 198–207 (2024)

    2024

  105. [114]

    arXiv preprint arXiv:2406.14150 (2024)

    Garau-Luis, J.J., Bordes, P., Gonzalez, L., al.: Multi-modal transfer learning between biological foundation models. arXiv preprint arXiv:2406.14150 (2024)

    2024 arXiv

  106. [115]

    arXiv preprint arXiv:2406.16860 (2024)

    Tong, S., Brown, E., Wu, P., al.: Cambrian-1: A fully open, vision-centric exploration of multimodal llms. arXiv preprint arXiv:2406.16860 (2024)

    2024 arXiv

  107. [116]

    arXiv preprint arXiv:2401.13601 (2024)

    Zhang, D., Yu, Y., Dong, J., al.: Mm-llms: Recent advances in multimodal large language models. arXiv preprint arXiv:2401.13601 (2024)

    2024 arXiv

  108. [117]

    In: Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pp

    Cha, J., Kang, W., Mun, J., al.: Honeybee: Locality-enhanced projector for multimodal llm. In: Proceedings of the IEEE/CVF Conference on Computer Vision and Pattern Recognition, pp. 13817–13827 (2024)

    2024

  109. [118]

    arXiv preprint arXiv:2312.13735 (2023)

    Chen, X., Li, S., Yang, Y., al.: Deco: Query-based end-to-end object detection with convnets. arXiv preprint arXiv:2312.13735 (2023)

    2023 arXiv

  110. [119]

    bioRxiv, 2024–0604596709 (2024)

    Zhai, J., Gokaslan, A., Schiff, Y., al.: Cross-species modeling of plant genomes at single nucleotide resolution using a pre-trained dna language model. bioRxiv, 2024–0604596709 (2024)

    2024

  111. [120]

    arXiv preprint arXiv:2403.03234 (2024) 26

    Schiff, Y., Kao, C.H., Gokaslan, A., al.: Caduceus: Bi-directional equivariant long-range dna sequence modeling. arXiv preprint arXiv:2403.03234 (2024) 26

    2024 arXiv

  112. [121]

    Nature 618(7965), 616–624 (2023)

    Theodoris, C.V., Xiao, L., Chopra, A., al.: Transfer learning enables predictions in network biology. Nature 618(7965), 616–624 (2023)

    2023

  113. [122]

    Nature Methods 18(10), 1196–1203 (2021)

    Avsec, Z., Agarwal, V., Visentin, D., al.: Effective gene expression prediction from sequence by integrating long-range interactions. Nature Methods 18(10), 1196–1203 (2021)

    2021

  114. [123]

    arXiv preprint arXiv:2407.04620 (2024)

    Sun, Y., Li, X., Dalal, K., al.: Learning to (learn at test time): Rnns with expressive hidden states. arXiv preprint arXiv:2407.04620 (2024)

    2024 arXiv

  115. [124]

    arXiv preprint arXiv:2409.04992 (2024)

    Pan, X., Li, E., Li, Q., al.: Instinfer: In-storage attention offloading for cost- effective long-context llm inference. arXiv preprint arXiv:2409.04992 (2024)

    2024 arXiv

  116. [125]

    arXiv preprint arXiv:2409.17264 (2024)

    Agrawal, A., Chen, J., Goiri, I., al.: Mnemosyne: Parallelization strategies for efficiently serving multi-million context length llm inference requests without approximations. arXiv preprint arXiv:2409.17264 (2024)

    2024

  117. [126]

    Nature Methods, 1–11 (2024)

    Hao, M., Gong, J., Zeng, X., al.: Large-scale foundation model on single-cell transcriptomics. Nature Methods, 1–11 (2024)

    2024

  118. [127]

    bioRxiv, 2023–0718549537 (2023)

    Heimberg, G., Kuo, T., DePianto, D., al.: Scalable querying of human cell atlases via a foundational model reveals commonalities across fibrosis-associated macrophages. bioRxiv, 2023–0718549537 (2023)

    2023

  119. [128]

    iScience 25, 104228 (2022)

    Kang, Y., Vijay, S., Gujral, T.S.: Deep neural network modeling identifies biomarkers of response to immune-checkpoint therapy. iScience 25, 104228 (2022)

    2022

  120. [129]

    Frontiers in Genetics 12, 806457 (2021)

    Liu, R., Dollinger, E., Nie, Q.: Machine learning of single cell transcriptomic data from anti-pd-1 responders and non-responders reveals distinct resistance mechanisms in skin cancers and pdac. Frontiers in Genetics 12, 806457 (2021)

    2021

  121. [130]

    Nature Immunology 18, 1274–1278 (2017)

    Rubelt, F., Busse, C.E., Bukhari, S.A.C., B¨ urckert, J.-P., Mariotti-Ferrandiz, E., al.: Adaptive immune receptor repertoire community recommendations for sharing immune-repertoire sequencing data. Nature Immunology 18, 1274–1278 (2017)

    2017

  122. [131]

    Frontiers in Big Data 3, 22 (2020)

    Christley, S., Aguiar, A., Blanck, G., Breden, F., Bukhari, S.A.C., al.: The adc api: a web api for the programmatic query of the airr data commons. Frontiers in Big Data 3, 22 (2020)

    2020

  123. [132]

    Annual Review of Chemical and Biomolecular Engineering 12(1), 39–62 (2021)

    Pertseva, M., Gao, B., Neumeier, D., al.: Applications of machine and deep learning in adaptive immunity. Annual Review of Chemical and Biomolecular Engineering 12(1), 39–62 (2021)

    2021

  124. [133]

    npj Digital Medicine 7(1), 67 (2024) 27

    Li, Y., Wu, X., Fang, D., al.: Informing immunotherapy with multi-omics driven machine learning. npj Digital Medicine 7(1), 67 (2024) 27

    2024

Pith tools

Reviewed August 11, 2026 · model on record in the stance chip above.